Weigao Group (01066) is currently up more than 8%, up 7.09% as of press time, at HKD 4.38, with a turnover of HKD 42.8063 million.
According to the WiseNews app, Weigao Group (01066) is currently up more than 8%, up 7.09% as of press time, at HKD 4.38, with a turnover of HKD 42.8063 million.
In terms of news, according to Caixin, Shanxi Aurel Bio-Engineering Material Co., Ltd. was suspected of illegally producing "heterologous bone implant materials," which has drawn widespread attention from society. Industry experts have expressed that with the implementation of the fourth batch of high-value consumables national procurement this year, the usage of heterologous bones (human bones) in hospitals will gradually decrease, and artificial bone repair materials will become the mainstream of the bone repair materials industry. Medical beauty industry insiders also expect that in the future, both medical beauty groups and related patients will pay more attention to the sources of related bone repair materials in bone repair surgery and shaping processes.
China Securities Co., Ltd. released a research report stating that the recent public opinion on heterologous bones has caused related companies in the artificial bone repair materials sector to rise, and artificial bones will to a certain extent replace heterologous bones in clinical use. The bank pointed out that the increase in compliance requirements in the medical industry since the middle of the third quarter of this year has led to a low base situation in the same period last year, and the gradual clearance of the impact of high-value consumables procurement in various fields such as electrophysiology, orthopedics, and artificial crystal, etc., would lead to the improvement of the performance certainty and valuation of related leading companies.